4.5 Review

Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression

Journal

INFLAMMATORY BOWEL DISEASES
Volume 28, Issue 9, Pages 1462-1464

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izac018

Keywords

biologics; speed of improvement; randomized controlled trials

Ask authors/readers for more resources

We conducted a systematic review and metaregression of pivotal Crohn's disease trials, finding that the speed of clinical improvement in Crohn's Disease Activity Index scores is similar among different biologic drug classes.
Lay Summary We conducted a systematic review and metaregression of pivotal Crohn's disease trials to evaluate the rates of change in Crohn's Disease Activity Index scores in patients receiving biologic treatments. The speed of clinical improvement was similar among biologic drug classes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available